CRISPR diagnostics: from trans-nuclease activity to cancer diagnosis

Lei Chang, Wenjue Xu, Xiaoyan Wang, Yuanyuan Xue, Ying Zhang, Xuena Zhu, Yun Zhang, Tingbo Liang, Wenjun Liu · 2026

Read CRISPR diagnostics: from trans-nuclease activity to cancer diagnosis by Lei Chang, Wenjue Xu, Xiaoyan Wang, Yuanyuan Xue, Ying Zhang, Xuena Zhu, Yun Zhang, Tingbo Liang, Wenjun Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13479867.txt.

Description

Lei Chang and coauthors published a 2026 review of CRISPR-based diagnostics, from the underlying enzyme trick to cancer detection. Nucleic acid testing stagnated for decades after the polymerase chain reaction, until 2016, when researchers found that CRISPR systems, once they find their target, begin shredding nearby DNA indiscriminately. Engineered reporter strands turn that shredding into a measurable signal.

A typical test runs in three phases: guided target recognition, signal conversion through reporter cutting, and readout by fluorescence, electricity, or color change. The approach proved itself during COVID-19 as a fast, low-equipment alternative to laboratory PCR. The review then turns to cancer, where detecting faint mutation signals in blood could enable earlier diagnosis, and weighs sensitivity limits that still separate promise from practice.

Catalog record

CREATORLei Chang, Wenjue Xu, Xiaoyan Wang, Yuanyuan Xue, Ying Zhang, Xuena Zhu, Yun Zhang, Tingbo Liang, Wenjun Liu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE147106
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13479867

Browse the full library · About the Tower of Babel